Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a non-recoverable (Fail-Stop) Pump Problem alarm. This may lead to delay of therapy, and patient may experience from no to minimal to serious harm. This issue was resolved in all fielded product in software version 5.2.1, which was installed in September 2022.
- Products
-
- LVP software of the Ivenix Infusion System (IIS)
- Company
- Fresenius Kabi USA, LLC
- Where it was sold
-
US Nationwide distribution in the states of WI and NJ.
States: New Jersey, Wisconsin
- Barcodes
00811505030122- Units affected
- 3
- About this recall
- LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004